Clinical Trials Browser

Recruiting × INDUSTRY × trilaciclib × Clear all

NCT05874401 2025-09-04

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Phase 4 Recruiting

Small Cell Lung Carcinoma